Data as of 12:42pm ET
| +0.36 / +3.61%|
The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 13.00, with a high estimate of 30.00 and a low estimate of 9.00. The median estimate represents a +25.85% increase from the last price of 10.33.
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.